|Bid||0.1150 x N/A|
|Ask||0.1200 x N/A|
|Day's Range||0.1150 - 0.1300|
|52 Week Range||0.0200 - 0.4850|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Apr. 07, 2006|
|1y Target Est||N/A|
In the news release, New Wave: Welcomes Iman Nevab, Homeopathic Research Expert to the Scientific Advisory Board, issued 21-Jan-2021 by New Wave Holdings Corp. over CNW, we are advised by the company that the headline should read "Iman Navab" rather than "Iman Nevab.
JOSEPH DEBUS, File No. 2019-16TORONTO, Jan.
TORONTO, Jan. 14, 2021 /CNW/ - NEW WAVE HOLDINGS CORP.